The DOI matches its Crossref record; 91 of the 96 references it cites were found in a registry or an index; 53 of the 113 sources its claims cite were checked for support.
The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review
Open accessAbstract
Background: Smoking is a substantial and avoidable risk for physical disability and premature death. Despite a declining tobacco use in the community of developed countries, smoking remains abundant in people with mental disorders. This narrative review highlights the epidemiology, consequences and treatment options of tobacco use disorder (TUD) and nicotine dependence (ND) in people with bipolar disorder (BD). Methods: The authors conducted a Medline literature search from 1970 to November 2022 using MeSH terms “bipolar disorder” x “smoking” or “nicotine” or “tobacco” that retrieved 770 results. Search results were complemented by additional literature retrieved from examining cross references and by hand search in text books. Finally, 92 references were considered as essential and selected for the educational purpose of this review. Summary of findings: Lifetime and point prevalence of smoking in people with BD is in the range of 45–70% and thus about 2–3 times more frequent in BD than in community samples. Smoking, TUD and ND have a detrimental impact both on mental and physical health as well as mortality in people with BD. In the absence of large controlled studies in comorbid BD and TUD or ND, pharmacological treatment follows the individual guidance for each disorder. Community-based psychosocial interventions for TUD and ND appear to be suitable in people with BD, too, as well as Cognitive Behavioral (CBT) or Acceptance and Commitment (ACT) based psychotherapies. Conclusions: Smoking is a modifiable risk factor causing increased risks both for mental and physical health in BD, and deserves more attention in treatment. More treatment research into pharmacological and psychosocial interventions in comorbid BD and TUD or ND are still needed to deliver evidence-based recommendations to physicians. Copyright © 2023 Grunze, Mosolov, Grunze and Born.
Overview
CoChat Summary
## TL;DR
This narrative review concludes that smoking, tobacco use disorder (TUD), and nicotine dependence (ND) are about 2–3 times more common in adults with bipolar disorder (BD) than in community samples and are linked to worse mental health, physical health, and mortality. The paper also argues that evidence for smoking-cessation treatment in BD is limited, but bupropion, varenicline, nicotine replacement therapy (NRT), and psychosocial approaches such as CBT and ACT all show promise.
## Key findings
- Lifetime and point prevalence of smoking in people with BD were reported to be in the 45–70% range, compared with 25–30% in the general population; the review also cites a pooled point prevalence of TUD/ND of 46.3% (95% CI 33.9–59.2%).
- In the US National Comorbidity Survey, the lifetime prevalence of daily smoking among adults with BD was 59% versus 39.1% in adults without mental disorders; a Kentucky study reported 66% everyday current smoking in people with BD.
- Smoking was associated with worse BD course and outcomes, including higher symptom load for mania, depression, and anxiety, more agitation and impulsivity, more hospitalizations, lower functionality, and more suicide attempts; in adolescents, 25% had ever smoked, 11% smoked daily, and half of daily smokers were heavy smokers (≥10 cigarettes/day).
- A bidirectional Mendelian randomization study in 20,129 cases and 21,524 controls found smoking to be an underlying risk factor for BD: OR 1.46 for smoking initiation and OR 1.72 for lifetime smoking; conversely, there was no unambiguous evidence that BD causally influenced smoking-related outcomes.
- For cessation treatment, the review identified only four published smoking-cessation treatment trials in smokers with BD; all were in favor of the specific treatment, and the paper notes limited evidence favoring bupropion, varenicline, or NRT.
## Methods
- Narrative review based on a Medline search on November 12, 2022 using MeSH terms for “bipolar disorder” crossed with “smoking,” “nicotine,” or “tobacco,” yielding 770 results; additional references were found through cross-references and textbook hand search.
- The authors selected 92 articles by consensus from the 770 references, prioritizing studies, reviews, meta-analyses, and opinion papers judged useful for educational purposes.
- The review summarizes epidemiology, biological mechanisms, consequences for mental and physical health, and pharmacological/psychosocial treatment options for comorbid BD and TUD/ND.
## Limitations
- The paper explicitly states it is “not a full and comprehensive review” and instead summarizes key studies and reviews according to the authors’ judgment.
- It notes that definitions of BD and of tobacco-related diagnoses changed over time, and that many prevalence studies did not use validated structured interviews, which likely contributes to the wide range of reported prevalence, correlates, and odds.
- Evident from the text: this is a narrative review, so its conclusions are limited by the underlying heterogeneous literature, and it reports that large controlled studies specifically in comorbid BD and TUD/ND are lacking.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
39 Valid · 5 Not valid · 36 Not checked · 11 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Smoking as a risk factor for an earlier age of onset of BD was also found in an Italian study in more than 1,000 patients of specialized outpatient clinics (41) and in a clinical sample of 195 adolescents from the US with BD (42).”
§ The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review > 7. Consequences of smoking in people with bipolar disorder > 7.1. Consequences for mental health The impact of smoking on the course of BD becomes noticeable quite early. Post-hoc analyses of the “Course and Outcome of Bipolar Youth (COBY)” study revealed that smoking is a worrisome concern in adolescents with BD. Twenty-five percent of the study participants had ever smoked, with 11 % daily, and half of them had been heavy smokers (≥10 cigarettes per day). Compared to those adolescents with BD who never smoked, smoking status was associated with a greater prevalence of BD-I, earlier onset of BD, higher lifetime prevalence of physical and sexual abuse as well as suicide attempts, conduct disorder, and other substance use disorders (SUD). In addition, previous psychiatric hospitalizations were significantly more frequent among daily smokers vs. those who never smoked (40). Smoking as a risk factor for an earlier age of onset of BD was also found in an Italian study in more than 1,000 patients of specialized outpatient clinics (41) and in a clinical sample of 195 adolescents from the US with BD (42). Heavy smoking in adolescents with BD also paves the way to heavier marijuana use, illicit drug use disorders, and poorer overall functioning (13). In adults with BD, smoking has also been associated with higher symptom load for mania, depression and anxiety (43, 44), more agitation and impulsivity (45, 46), more hospitalizations, lower functionality and more suicide attempts (6, 47, 48). In addition, dimensional analysis in smokers with BD (number of cigarettes per day vs. different clinical variables) reports a positive correlation for number of daily cigarettes and age, age at onset of BD, illness duration, and a current diagnosis of comorbid panic disorder (44), the latter being a frequent comorbidity in BD. Of note, not only smoking, but also cessation of smoking puts people with BD on increased mental health relapse risk. When stopping smoking, people with BD may also have a transient increased risk of a manic or depressive recurrence (49–51).
What the sources say
- Partly supportedcites [41] Miola, 2022, Factors associated with onset-age in major affective disorders, Acta Psychiatr Scand. sourceExperimental — accuracy not yet measured
The Results (Table 2) show that tobacco smoking was more common among patients with onset before 18 than among those with onset after 40 in a cohort of 1,033 patients. But the comparison combines bipolar and major depressive disorders, and the paper describes an association rather than establishing smoking as a risk factor for earlier bipolar onset. (LLM, conf=0.87)
- Disputedcites [42] Barton, 2022, Prevalence and correlates of childhood-onset bipolar disorder among adolescents, Early Interv Psychiatry. sourceExperimental — accuracy not yet measured
The Discussion (pp. 8–9) reports the opposite association in the study’s 195 adolescents with bipolar disorder: childhood-onset was negatively associated with lifetime smoking. The Multivariate analyses (p. 7) also report a significant negative association. The paper does not establish smoking as a risk factor for earlier onset. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a causen = 1,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“but with all three pharmacological interventions (bupropion, varenicline, NRT) being, by large, equally effective for TUD or ND (80)”
§ The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review > 8. Treatment of comorbid bipolar disorder and tobacco use disorder > 8.2. Pharmacological treatment of tobacco use disorder or nicotine dependence in people with bipolar disorder There is an obvious paucity of profound research and, as a consequence, a relative lack of published studies on the psychopharmacological treatment of BD comorbid with TUD or ND. As a matter of fact, our systematic literature search revealed that not a single double-blind placebo-controlled study has been conducted exclusively in this population. In general, nicotine metabolism is similar across smokers with BD and healthy subjects. Nicotine is metabolized in the liver by the cytochromes (CYP) 2A6 (~0.90%) and CYP 2B6 (~10%) (67). People with BD taking hepatic enzyme-inducing drugs such as carbamazepine, oxcarbazepine or topiramate have an increased nicotine metabolism, possibly resulting in the urge of heavier smoking and making it more difficulty to quit smoking (68). This metabolic pathway also opens the door to interactions with some psychotropic medication metabolized by CYP 2A6, namely valproate, or CYP 2B6 (bupropion). Due to the large metabolic capacities of these cytochromes, interactions are only in exceptional cases of clinical relevance. As far as interaction with psychotropic drugs in concerned, polycyclic aromatic hydrocarbons within tobacco smoke play a more decisive role by inducing CYP1A2 (Table 1). The clinical significance of such interactions has been demonstrated for olanzapine and haloperidol treatment in a post-hoc analysis of the Phase 3 olanzapine mania studies by Berk and colleagues (69). Smokers and non-smokers with mania of comparable severity had diverging treatment outcomes, with those who continued smoking showing overall poorer clinical outcomes vs. those who did not smoke during the trials. We identified only four published smoking cessation treatment trials in smokers with BD: one very small open pilot study with bupropion (70), two open pilot studies with varenicline (71, 72), and 2 studies using varenicline either alone (73) or in combination with CBT (74). All studies were in favor of the specific treatment. However, as this evidence base is quite limited, in clinical practice people with BD usually receive the same treatments for TUD or ND as smokers not affected by mental health disorders.
What the sources say
- Disputedcites [80] Pearsall, 2019, Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials, BMJ Open. sourceExperimental — accuracy not yet measured
The Results section reports different three-month effects: bupropion and varenicline each had a number needed to treat of 6, while NRT had a number needed to treat of 15 and was described as the least effective. The Discussion also calls varenicline the most successful treatment and says evidence does not support bupropion or nicotine products for cessation beyond three months. The review therefore does not support describing all three as broadly equally effective. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, preliminary data from diffusion tensor imaging (DTI) studies report that smoking in young adulthood elevates fractional anisotropy (FA) among smokers compared to non-smokers (34), suggestive of impaired white matter development that might increase vulnerability to severe mental disorders.”
§ The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review > 5. Biological effects of smoking
What the sources say
- Partly supportedcites [34] Gogliettino, 2016, White matter development and tobacco smoking in young adults: A systematic review with recommendations for future research, Drug Alcohol Depend. sourceExperimental — accuracy not yet measured
The Abstract Results and Discussion §4.1 report higher fractional anisotropy (FA) in adolescent and young adult smokers than in non-smokers. But Discussion §4.3 says it remains unclear whether smoking causes the white-matter differences, and §4.1 says the meaning of increased FA needs further study. The review therefore does not establish that smoking elevates FA or that the finding indicates impaired white-matter development. (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Analysis of the large database of the Genomic Psychiatry Cohort (GPC) revealed that among smokers, those with BD had a significantly increased risk of ND (OR = 2.5).”
§ The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review > 4. Genetic predisposition
What the sources say
- Supportedcites [23] Estrada, 2016, Nicotine dependence and psychosis in Bipolar disorder and Schizoaffective disorder, Bipolar type, Am J Med Genet Part B, Neuropsychiatric Genet. source
The Methods (Sample and Analyses; page unavailable) identify the Genomic Psychiatry Cohort as the data source. The Results (page unavailable) report that among smokers, bipolar disorder was associated with increased nicotine-dependence risk (OR=2.5; p<0.0001), supporting the claim of statistical significance. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although ND is a predictor for developing BD (19), the genetic association, however, of ND and TUD with BD is less clear.”
§ The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review > 4. Genetic predisposition
What the sources say
- Supportedcites [19] Martínez-Ortega, 2013, Temporal sequencing of nicotine dependence and bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), J Psychiatr Res. source
The Results section reports that prior nicotine dependence was associated with an increased risk of developing bipolar disorder. The paper treats this as prediction, not proof that nicotine dependence causes bipolar disorder. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
50 more claims · 23 with their cited sources checked
Create a free account to see all 91 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 35
- Probably not a substantial claim. 4
Citations
Cites
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
23andMe Research Team, Liu, M., Psychiatry, H. A.-I., Jiang, Y., Wedow, R., Li, Y., Brazel, D. M., Chen, F., Datta, G., Davila-Velderrain, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0307-5 · Cited by 1,896 · cited 1×
“In a recent genome-wide association study (GWAS) of smoking, smoking initiation and severity, and BD no genetic correlation could be established whereas smoking and schizophrenia appeared genetically correlated (20).”
BackgroundSmoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576 · cited 2×
“Despite a declining tobacco use in the general population in developed countries, smoking remains abundant in people with mental disorders (1).”
BackgroundGenome-wide association study identifies 30 loci associated with bipolar disorder
eQTLGen Consortium, Stahl, E. A., BIOS Consortium, the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Breen, G., Forstner, A. J., McQuillin, A., Ripke, S., Trubetskoy, V., Mattheisen, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0397-8 · Cited by 1,519
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Estimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247
Firth, J., Solmi, M., Wootton, R. E., Vancampfort, D., Schuch, F. B., Hoare, E., Gilbody, S., Torous, J., Teasdale, S. B., Jackson, S. E., et al. (2020) · World Psychiatry · doi:10.1002/wps.20773 · Cited by 1,242
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · cited 1×
“In addition, nicotine has a cascading effect on central neurotransmission also resulting in the release of norepinephrine and histamine as well as GABA and glutamate (28, 29).”
Background
Research works printed but not linked: 2
- 2013, Diagnostic and Statistical Manual of Mental Disorders. 5th ed
- Trushchelev, 2019, Organizational and methodological aspects of the tobacco addiction treatment, Curr Ther Mental Disord., 4, 19
Cited by
Messina, A., Caraci, F., Aguglia, E., & Signorelli, M. S. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00471-0 · Cited by 12
Howland, M., Mahajan, A., Chen, P., Almeida, O. P., Altınbaş, K., Blumberg, H. P., Dols, A., Fiorelli, N. M., Forlenza, O. V., Lafer, B., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251387658 · Cited by 2
“1,2 Smoking has been associated with greater BD symptom severity and suicidality, 3 – 5 which may be secondary to smoking-induced oxidative stress or neuroin fl am-mation 6,7 and BD treatment non-adherence.”
Botsari, I. A., Marouli, G., Arvanitaki, A., & Peritogiannis, V. (2023) · Healthcare · doi:10.3390/healthcare11050642 · Cited by 1
“Recent research has shown that smoking may be associated with earlier onset of bipolar disorder, higher prevalence of suicide attempts, other substance use disorders, more frequent hospitalizations, more symptoms, poor functioning and a worse prognosis, along with the well-known effects on physical health [26].”
Risk Factors for Natural Cause Mortality in Bipolar Disorder
Dickerson, F., Khan, S., Origoni, A. E., Rowe, K. C., Katsafanas, E., Mukhtar, F., & Yolken, R. H. (2026) · Bipolar Disorders · doi:10.1111/bdi.70092 · Cited by 1
“It is well established that persons with bipolar disorder, like other persons with serious mental illness, are more likely to be tobacco smokers than those in the general population [45, 46].”
Naknoi, S., Nichachotesalid, P., Sungbun, S., et al. (2024) · Journal of Health Research · doi:10.56808/2586-940x.1111
Metadata
- Authors
- Grunze, A., Mosolov, S., Grunze, H., & Born, C.
- Affiliations
- Russian Medical Academy of Continuous Professional Education (RU)
- Paracelsus Medizinische Privatuniversität (DE)
- Corresponding author
- Grunze, Heinz
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2023-01-09
- Volume
- 13
- Pages
- 1114432-1114432
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC9870053
- OpenAlex
- W4313823871
- Semantic Scholar
- 841501d0c2f8f6d2d72643a5518cdc5a4abe8720
- Cited by
- 11
- References
- 96
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 1 · 2023: 2
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- bipolar disorder, smoking, tobacco use disorder, nicotine dependence, comorbidities, smoking prevalence, mortality, physical health, mental health, psychosocial interventions, cognitive behavioral therapy, acceptance and commitment therapy, pharmacotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review. https://app.cochat.ai/papers/10.3389/fpsyt.2022.1114432
- The paper
- Grunze, A., Mosolov, S., Grunze, H., & Born, C. (2023). The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.1114432
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.